Views | |
---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 72 |
April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | |
---|---|---|---|---|---|---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 1 | 2 | 1 | 1 | 10 | 3 | 3 |
Views | |
---|---|
2019_Ertaş_etal.pdf | 161 |
2019_Ertaş_etal.pdf | 6 |